Overview

A Pilot Study of Daptomycin for Antimicrobial Prophylaxis

Status:
Terminated
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
The goals of the study are to evaluate the feasibility of using daptomycin as a prophylactic antimicrobial agent in patients undergoing cardiac surgery, to determine the rates of surgical site infection, and to evaluate the occurrence of adverse events.
Phase:
Phase 4
Details
Lead Sponsor:
Duke University
Collaborator:
Cubist Pharmaceuticals LLC
Treatments:
Anti-Infective Agents
Daptomycin
Methicillin